The effect of phenylephrine infusion on the dose requirement of prophylactic oxytocin for the prevetion of postpartum uterine atony in parturients undergoing cesarean delivery.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018979

Enrollment

Unknown

Registered

2018-10-20

Start date

2018-11-01

Completion date

Unknown

Last updated

2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

Group P:phenylephrine

Group C:saline

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: healthy parturients with an ASA statue of I or II, single pregnant.

Exclusion criteria

Exclusion criteria: Patients with obesity (body mass index, BMI > 35 kg/m2), gestational age < 37 weeks, active labor, early labor, ruptured membranes, history of previous cesarean deliveries, diabetes or gestational diabetes, hypertension or pre-eclampsia, intrauterine growth restriction, placenta previa, significant coexisting maternal disease, any contraindication to spinal or epidural anesthesia such as local infection or bleeding disorders.

Design outcomes

Primary

Measure	Time frame
dose of oxytocin;loss of blood;	—

Countries

China

Contacts

Public ContactXiao Fei

Jiaxing Maternity and Child Care Hospital, Jiaxing University Affiliated Women and Children Hospital544

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026